Provided by Tiger Trade Technology Pte. Ltd.

Amgen

431.02
-1.4000-0.32%
Volume:383.55K
Turnover:164.89M
Market Cap:232.10B
PE:26.77
High:431.85
Open:428.59
Low:426.00
Close:432.42
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.51
T/O Rate:0.07%
Dividend:9.80
Dividend Rate:2.27%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:19.86
PE(LYR):30.29

Loading ...

Cue Biopharma Names Dominic Borie Chief Medical Officer, Head of R&D

Reuters
·
Jul 13

Amgen is Maintained at Neutral by Guggenheim

Dow Jones
·
Jul 13

BMO Capital Sticks to Their Buy Rating for Amgen (AMGN)

TIPRANKS
·
Jul 13

Sino Biopharmaceutical Stock Advances 3.8% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 10

Amgen Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 10

Sino Biopharmaceutical Stock Rises 3.7% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 09

Amgen Targets Carbon Neutrality by 2027 for Owned, Operated Facilities and Operations

Reuters
·
Jul 09

Amgen is Maintained at Equal-weight by Morgan Stanley

Dow Jones
·
Jul 09

Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says

MT Newswires Live
·
Jul 08

Amgen price target raised to $340 from $327 at Truist

TIPRANKS
·
Jul 07

Truist Securities Adjusts Amgen Price Target to $340 From $327

MT Newswires Live
·
Jul 07

Movement Alert|Amgen Falls 3.19% in Regular Trading, Biotech Sector Under Pressure as Tavneos EU Market Withdrawal Risk Escalates

Market Focus
·
Jul 06

Nike, Amgen Share Losses Lead Dow's 238-point Drop

Dow Jones
·
Jul 06

Amgen Price Target Maintained with a $350.00/share by Cantor Fitzgerald

Dow Jones
·
Jul 06

Rothschild & Co Redburn Adjusts Price Target on Amgen to $220 From $200

MT Newswires Live
·
Jul 06

Sino Biopharmaceutical Stock Rallies 6.5% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 06

Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Macro World​
·
Jul 06

Amgen (AMGN) Could Be 45% Below Fair Value As Court Blocks Enbrel Price Cap

Simply Wall St.
·
Jul 06

Sino Biopharmaceutical Stock Climbs 2.6% in Hong Kong

Dow Jones
·
Jul 03

Amgen’s Rocatinlimab Asthma Trial Reaches Phase 2 Finish Line

TIPRANKS
·
Jul 03